Bio-Techne Corp reports results for the quarter ended June 30 - Earnings Summary
I'm PortAI, I can summarize articles.
Bio-Techne Corp reported adjusted earnings of 53 cents per share for the quarter ended June 30, exceeding last year's 49 cents and analysts' expectations of 50 cents. Revenue increased by 3.5% to $316.96 million, slightly above the expected $315.60 million. However, the company reported a loss of 11 cents per share and a quarterly loss of $17.68 million. Despite a 6.2% rise in shares this quarter, they have fallen 24.1% year-to-date. Analysts maintain a "buy" rating with a median 12-month price target of $65.00, 15.9% above the last closing price of $54.64.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments